All COVID-19 articles
-
NewsBreakthrough in coronavirus fight: scientists develop powerful bispecific inhibitor to combat a wide range of coronaviruses
Researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid.
-
NewsSafer, more effective vaccines with new mRNA vaccine technology
A new messenger ribonucleic acid (mRNA) vaccine technology could make future vaccines safer, more effective, and less burdensome for patients. The new approach uses albumin-recruiting lipid nanoparticles to deliver mRNA precisely to lymph nodes while bypassing the liver.
-
NewsTracking infectious disease spread via commuting pattern data
Researchers have introduced a Commuter Metapopulation Model (CMPM) to simulate the spread of COVID-19 with actual commuting data provided by the country’s second-largest telecommunication network, revealing it could better capture spatial variety in outbreak patterns.
-
NewsWHO upgrades its public health intelligence system to boost global health security
The World Health Organization (WHO) has launched version 2.0 of the Epidemic Intelligence from Open Sources (EIOS) system, used globally for the early detection of public health threats.
-
NewsProtein nanorings designed to detect and neutralize SARS-CoV2 virus
Scientists have generated a new ring-shaped protein nanomaterial capable of strongly binding to and neutralising the SARS-CoV2 virus. The new nanomaterial is formed by a scaffold based on recombinant ring-like proteins (RLPs), to which mini proteins were incorporated.
-
NewsResearch team with the latest Nobel Prize laureate reveals regulatory immune cell precursors disrupted in severe COVID-19
A research team joined by Professor Shimon Sakaguchi – the latest Nobel Laureate in Physiology or Medicine – has identified a subset of immune cells called precursor T follicular regulatory cells (preTfr) that play a critical role in preventing autoantibody production.
-
NewsScientists blaze new path to fighting viral diseases
Scientists have identified a potential new drug against the virus that causes COVID-19 - and devised a powerful new platform for finding medicines to fight many types of infectious diseases. Compound 6, led SARS-CoV-2 viral proteins to misfold, malfunction, and ultimately, be destroyed and removed by cells, in lab tests.
-
NewsHeart rhythm disorder POTS common in patients with long COVID
A new study shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those affected are middle-aged women.
-
NewsPotential biomarker for the development of long COVID identified
A research team has demonstrated that a specific component of the immune system (PTX-3) remains at significantly higher levels in the blood of patients who have suffered from severe COVID-19, even months after the acute infection has subsided.
-
NewsBrain imaging technique helps uncover the molecular basis of long COVID brain fog
A research team has made a significant breakthrough in understanding the cause of Long COVID brain fog. They hypothesized that patients with brain fog might exhibit disrupted expression of AMPA receptors (AMPARs)based on prior research into psychiatric and neurological disorders.
-
NewsUnder half in US would recommend some routine vaccinations during pregnancy
Data from a new APPC health survey finds a reluctance among the public to recommend that someone who is pregnant get a Covid-19 vaccine, with just 38% saying they would do so. Less than half of the survey respondents (42%) say it is safe to take an mRNA Covid-19 vaccine during pregnancy.
-
NewsRisk of long COVID in kids doubles after second infection
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, results running counter to the popular perceptions that COVID in children is ‘mild’.
-
NewsBeyond viruses: Expanding the fight against infectious diseases
The newly renamed Gladstone Infectious Disease Institute has broadened its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.
-
NewsMeta-analysis: COVID-19 vaccination during pregnancy is safe and beneficial for mother and infant
Vaccination is associated with better neonatal outcomes without added maternal risk, according to research presented during the American Academy of Pediatrics 2025 National Conference & Exhibition.
-
NewsStudy models how human behavior, lockdowns and restrictions shaped COVID’s spread
Researchers employed computer modeling and large datasets to better understand how COVID-19 was transmitted in one community in South Africa during the course of the worldwide pandemic.
-
NewsTropical diseases: Global health meeting showcases resilience of field under fire
At a moment of monumental challenges for global health, thousands of researchers, clinicians and public health professionals from over 100 countries will gather in Toronto for the 2025 Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
-
NewsNext-gen anti-bacterial and anti-viral surface modification technology inspired by Korean mussels
Researchers have successfully developed a next-generation surface modification technology with anti-bacterial and anti-viral contamination properties.While maximizing the bactericidal effect, a polydopamine layer, combined with an antibiotic, inhibits the adsorption of coronavirus.
-
NewsMajor report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.
-
NewsScientists identify four ways our bodies respond to COVID-19 vaccines
Researchers tracked individuals’ antibody levels after vaccinations and identified four distinct patterns of immune response after the first booster, suggesting that monitoring how antibody levels change over time could assist in identifying individuals at greater risk of infection.
-
NewsUS COVID-19 school closures were not cost-effective - but other non-pharmaceutical interventions were
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research analysing non-pharmaceutical interventions in the United States.